Cytek Biosciences CTKB
$6.12 −$0.20 (-3.16%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $6.12 0.00%
Open$6.31
Prev close$6.32
Day range$5.99 – $6.39
Volume1.77M
Market cap$800.40M
P/E (TTM)–
Dividend yield–
CTKB Stock News
Headlines matching Cytek Biosciences or the CTKB ticker, most recent first.
- Piper Sandler Maintains Cytek Biosciences(CTKB.US) With Buy Rating, Maintains Target Price $7.5
- Morgan Stanley Maintains Cytek Biosciences(CTKB.US) With Hold Rating, Cuts Target Price to $5 Negative
- TD Cowen Maintains Cytek Biosciences(CTKB.US) With Hold Rating, Maintains Target Price $5
- Stephens Maintains Cytek Biosciences(CTKB.US) With Buy Rating, Raises Target Price to $4.75 Positive
- Morgan Stanley Maintains Cytek Biosciences(CTKB.US) With Hold Rating, Cuts Target Price to $4.12 Negative
- TD Cowen Maintains Cytek Biosciences(CTKB.US) With Hold Rating, Raises Target Price to $5 Positive
- Piper Sandler Maintains Cytek Biosciences(CTKB.US) With Buy Rating, Maintains Target Price $7.5
- Stephens Maintains Cytek Biosciences(CTKB.US) With Buy Rating, Raises Target Price to $7 Positive
- Stephens Maintains Cytek Biosciences(CTKB.US) With Buy Rating, Raises Target Price to $6 Positive
- Piper Sandler Maintains Cytek Biosciences(CTKB.US) With Buy Rating, Maintains Target Price $8
- Morgan Stanley Maintains Cytek Biosciences(CTKB.US) With Hold Rating, Cuts Target Price to $7 Negative
- Stephens Maintains Cytek Biosciences(CTKB.US) With Buy Rating, Cuts Target Price to $4 Negative
- TD Cowen Downgrades Cytek Biosciences(CTKB.US) to Hold Rating, Cuts Target Price to $4 Negative
- Piper Sandler Maintains Cytek Biosciences(CTKB.US) With Buy Rating, Cuts Target Price to $8 Negative
- Morgan Stanley Maintains Cytek Biosciences(CTKB.US) With Hold Rating, Maintains Target Price $9
No comments yet — be the first to weigh in on CTKB.
Sign in to join the discussion.